Document Detail


Removal of xenoreactive human anti-pig antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Gal alpha1,3Gal epitope.
MedLine Citation:
PMID:  9197365     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The hyperacute rejection caused by preformed natural antibodies in the recipient species reacting with donor species endothelial antigens is one of the major obstacles preventing routine use of clinical xenotransplantation. Based on the known structure and biosynthetic pathway of the major porcine xenoantigen, Gal alpha1,3Gal, we developed a novel strategy aimed at specific removal of human, natural anti-pig antibodies. METHODS: Cotransfection of COS cells with expression plasmids encoding a secreted mucin/immunoglobulin chimera and the porcine alpha1,3-galactosyltransferase facilitated simple immunoaffinity purification of a highly Gal alpha1,3Gal-substituted mucin/immunoglobulin fusion protein from transfected cell supernatants. RESULTS: Cotransfection of COS cells resulted in a mucin/Ig concentration in the supernatants ranging from 150 to 200 ng/ml. Approximately 300 ng of mucin/Ig chimeras absorbed onto 50 microl of packed anti-mouse IgG agarose beads could completely remove cytotoxic human anti-pig antibodies from 1 ml of human AB serum, as estimated in porcine endothelial cell cytotoxicity assays. Purified human IgG, IgM, and IgA all bound porcine endothelium, but only IgG and IgM were cytotoxic in the presence of rabbit complement. When the cytotoxicity of human IgG at 8 mg/ml and IgM at 1 mg/ml was completely removed by absorption on the mucin/Ig chimera, the binding to porcine endothelium was only partly reduced. Antibodies mediating antibody-dependent cellular cytotoxicity against porcine endothelium were also absorbed, indicating the importance of Gal alpha1,3Gal epitopes for this effect. CONCLUSIONS: We describe the construction and production of a new and effective Gal alpha1,3Gal-substituted, mucin domain-containing absorber that can be used in a pretransplant extracorporeal immunoabsorption setting to remove anti-pig antibodies involved in antibody-dependent, complement- and cell-mediated cytotoxicity of pig endothelial cells.
Authors:
J Liu; Y Qian; J Holgersson
Related Documents :
7000705 - Immune response in rabbits to surface components of extracellular and intracellular for...
21903095 - Development and validation of a standardized elisa for the detection of soluble fc-epsi...
59945 - Impact of ig-anti-ig column fractionation on t-lymphocyte functions.
1351885 - A combination of two immunotoxins exerts synergistic cytotoxic activity against human b...
17021245 - Development of novel immunoglobulin g (igg), iga, and igm enzyme immunoassays based on ...
18199635 - Structural basis for potent cross-neutralizing human monoclonal antibody protection aga...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Transplantation     Volume:  63     ISSN:  0041-1337     ISO Abbreviation:  Transplantation     Publication Date:  1997 Jun 
Date Detail:
Created Date:  1997-07-09     Completed Date:  1997-07-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0132144     Medline TA:  Transplantation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1673-82     Citation Subset:  IM    
Affiliation:
Division of Clinical Immunology, Karolinska Institute, Huddinge University Hospital, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Absorption
Animals
Antibodies / pharmacology*
Antibody Affinity
Antibody-Dependent Cell Cytotoxicity
COS Cells / secretion
Disaccharides / immunology
Epitopes
Galactose / immunology*
Glycoproteins / chemistry*,  immunology
Graft Rejection / immunology
Humans
Immunosorbent Techniques
Mucins / metabolism*
Recombinant Proteins / metabolism
Swine
Transplantation, Heterologous / immunology*
Chemical
Reg. No./Substance:
0/Antibodies; 0/Disaccharides; 0/Epitopes; 0/Glycoproteins; 0/Mucins; 0/Recombinant Proteins; 26566-61-0/Galactose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stabl...
Next Document:  En bloc pancreas and kidney transplantation in a patient with limited vascular access.